Monitoring for medication errors in outpatient settings

Area of Science:

• Dermatology
• Pharmacovigilance
• Patient Safety

Background:

• Medication errors and adverse drug events (ADEs) pose a significant problem in dermatology.
• Existing reporting systems are primarily focused on inpatient settings, leaving a gap in outpatient care.
• Vigilant reporting is essential for understanding and mitigating medication-related harm in dermatological conditions.

Purpose of the Study:

• To review current medication error reporting systems.
• To focus on outpatient settings and topical medications used for dermatological diseases.
• To identify opportunities for improved tracking and reporting of medication errors in dermatology.

Main Methods:

• A literature search was conducted using terms like 'medication error', 'outpatient settings', 'barriers', 'CPOE', 'dermatological conditions', and 'skin disorders'.
• The review focused on identifying existing reporting mechanisms and their limitations in the context of dermatological treatments.

Main Results:

• Medication-related incidents in inpatient settings range from 4.49 to 24.1 per 1000 patient days.
• Patient errors constitute the majority (56%) of medication errors, followed by prescription (13%), delivery (13%), availability (10%), and reporting errors (8%).
• Computerized prescriber order entry (CPOE) systems can enhance safety but may introduce new issues like interface problems and human errors.

Conclusions:

• There is a clear need for enhanced medication error tracking and reporting systems within dermatology outpatient settings.
• Developing systems to ensure patients comprehend topical medication usage is vital for improving safety and reducing ADEs.
• Addressing patient-related errors is a key area for intervention.